Type IV Collagen Serum and Vitreous Fluid Levels in Patients with Diabetic Retinopathy

We compared the levels of type IV collagen (IV-C) in vitreous fluid and serum and the levels of glycosylated haemoglobin in 47 patients with proliferative diabetic retinopathy (DR) and 21 patients with non-inflammatory retinopathies. Levels of IV-C were found to be higher in the vitreous fluid in patients with DR than in patients with non-inflammatory retinopathy (53.2 ± 14.9 μg/l versus 14.7 ± 4.5 μg/l). Serum levels were likewise higher in patients with DR (349.7 ± 106.2 μg/l versus 97.7 ± 13.1 μg/l) as were glycosylated haemoglobin levels (8.3 ± 0.3% versus 5.2 ± 0.4%). In addition, levels of type IV collagen in the vitreous fluid were found to be higher in the patients who had been diabetic for ≥ 10 years than in patients who had been diabetic for < 10 years (54.8 ± 15.5 μg/l versus 16.8 ± 4.6 μg/l). We conclude that accumulation of vitreous fluid IV-C may relate to high levels of glycosylated haemoglobin and long duration of diabetes. This suggests that the concentration of IV-C in vitreous fluid, and possibly also the serum levels of IV-C, reflects the progression of DR. Further investigation is needed to verify this and to investigate whether or not measuring IV-C levels is a useful means to assess therapeutic effects and/or prognosis of diabetic microangiopathy.

[1]  H. Morita,et al.  Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. , 1999, Kidney international. Supplement.

[2]  M. Cooper,et al.  Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies. , 1998, Metabolism: clinical and experimental.

[3]  J. Mott,et al.  Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. , 1997, Kidney international.

[4]  G. Romeo,et al.  Upregulation of Mesangial Growth Factor and Extracellular Matrix Synthesis by Advanced Glycation End Products Via a Receptor-Mediated Mechanism , 1997, Diabetes.

[5]  A. Ooshima,et al.  Serum Type IV Collagen Concentrations in Diabetic Patients With Microangiopathy as Determined by Enzyme Immunoassay With Monoclonal Antibodies , 1990, Diabetes.

[6]  D. Noonan,et al.  Altered Steady-State mRNA Levels of Basement Membrane Proteins in Diabetic Mouse Kidneys and Thromboxane Synthase Inhibition , 1990, Diabetes.

[7]  A. Ooshima,et al.  One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[8]  C. Abrass,et al.  Phenotypic Expression of Collagen Types in Mesangial Matrix of Diabetic and Nondiabetic Rats , 1988, Diabetes.

[9]  J. Risteli,et al.  Type IV collagen and laminin‐related antigens in human serum in alcoholic liver disease , 1985, European journal of clinical investigation.

[10]  A. Michael,et al.  Polyantigenic Expansion of Basement Membrane Constituents in Diabetic Nephropathy , 1983, Diabetes.

[11]  R. Timpl,et al.  A network model for the organization of type IV collagen molecules in basement membranes. , 1981, European journal of biochemistry.

[12]  T. Kanda,et al.  Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus. , 2000, Journal of diabetes and its complications.

[13]  M. Cooper,et al.  SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy. , 2000, Microvascular research.

[14]  R. Kleinert,et al.  [Immunohistologic studies of the vitreous humor]. , 1998, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.